Anticancer Therapies – Multimedia

As we have gained a greater understanding of cancer biology, therapeutic interventions have evolved from a one-size-fits-all approach to more targeted approaches, which afford patients not only longer lives but increased quality of life.

Download this app note to discover immunoassay platforms that are consistent for your cell therapy and immunology development needs.

Cell-based chimeric antigen receptor (CAR) T-cell therapies have rapidly advanced from preclinical research. This success has driven an influx of companies to further develop CAR T-cell constructs to make them more effective, safe and persistent.

For this Teach Me in 10 episode we are joined by Michael Hinterberg from Soma Logic who provides an overview and inspiration for obtaining and analyzing high-dimensional proteomic data. He also shows how proteomic data are readily accessible for exploratory data analysis and hypothesis testing to those who are already familiar with genomic analysis or traditional statistics in other scientific fields.

A new study led by Scripps Research scientist Howard Hang, PhD, explains how and why a certain species of bacteria in the digestive tract significantly improves the tumor-fighting ability of approved cancer drugs known as checkpoint inhibitors.

In this Teach Me in 10, we are joined by Dr. Clare Paterson from SomaLogic. Dr. Paterson discusses the power of proteomics, exploring how proteomics has evolved from assessments of single analytes to sensitive, specific and high throughput technologies capable of generating a wealth of invaluable data.

In this episode, the Technology Networks team reviews world-leading research into the mechanisms behind endometriosis, a condition that affects up to 10% of women of reproductive age, but often takes a decade to diagnose. There's also a peek into mom's brain during birth and a new cancer vaccine that harnesses similar technology used to create the Oxford–AstraZeneva COVID-19 vaccine.

Cancer immunotherapy relies on activating or enhancing the antitumor immune response and has taken a central position in cancer treatment modalities. However, not all patients respond to immunotherapy.

Download this listicle to learn about recent advances in cell-based therapies including off-the-shelf chimeric antigen receptor (CAR) T-cell therapy, engineered T-cell receptor therapy and mesenchymal stem cell therapies.

Since its release in 2011, canSAR has become the largest, public, cancer drug discovery resource in the world. It brings together billions of pieces of experimental data across disciplines – biology, chemistry, pharmacology, structural biology, cell biology – with clinical insights.